Prestige Consumer Healthcare (PBH)
(Real Time Quote from BATS)
$57.09 USD
-1.03 (-1.77%)
Updated Jun 28, 2022 03:08 PM ET
4-Sell of 5 4
B Value C Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$57.09 USD
-1.03 (-1.77%)
Updated Jun 28, 2022 03:08 PM ET
4-Sell of 5 4
B Value C Growth F Momentum C VGM
Zacks News
Prestige Consumer (PBH) Brand-Building Efforts Solid, Costs High
by Zacks Equity Research
Prestige Consumer (PBH) is benefiting from its solid brand-building efforts and growing e-commerce business.
Prestige Consumer (PBH) Stock Up on Q4 Earnings & Revenue Beat
by Zacks Equity Research
Prestige Consumer's (PBH) fourth-quarter results benefit from strong consumer demand and strength in certain categories that were earlier affected by the pandemic.
Prestige Brands (PBH) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Prestige Brands (PBH) delivered earnings and revenue surprises of 2.25% and 3.38%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Central Garden (CENT) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Central Garden (CENT) delivered earnings and revenue surprises of 7.63% and 2.06%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Prestige Consumer (PBH) in Q4 Earnings?
by Zacks Equity Research
Prestige Consumer's (PBH) fourth-quarter results are likely to reflect high demand for certain categories and gains from buyouts, while high costs are a concern.
Prestige Consumer (PBH) Hurt by High Costs, Solid Demand Aids
by Zacks Equity Research
Prestige Consumer Healthcare (PBH) is battling elevated cost and supply-chain challenges, while domestic consumer healthcare demand for certain categories has been aiding the company.
Prestige Consumer (PBH) Well Poised on Solid Brand, E-Commerce
by Zacks Equity Research
Prestige Consumer Healthcare (PBH) has been gaining on its robust brand portfolio. Prudent acquisitions and e-commerce strength are working well for the company.
What Makes Prestige Brands (PBH) a New Buy Stock
by Zacks Equity Research
Prestige Brands (PBH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Prestige Consumer (PBH) Rises on Q3 Earnings Beat, Raised View
by Zacks Equity Research
Prestige Consumer's (PBH) third-quarter results benefit from strong consumer demand and the strength in certain categories that were earlier affected by the pandemic. Management ups fiscal 2022 view.
Prestige Brands (PBH) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Prestige Brands (PBH) delivered earnings and revenue surprises of 11.24% and 5.57%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Factors to Know Ahead of Prestige Consumer (PBH) Q3 Earnings
by Zacks Equity Research
Gains from brand-building strategies, e-commerce operations and buyouts might contribute to Prestige Consumer's (PBH) third-quarter fiscal 2022 results.
Prestige Brands (PBH) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Value Investors Consider Prestige (PBH) Stock Now?
by Zacks Equity Research
Let's see if Prestige (PBH) stock is a good choice for value-oriented investors right now from multiple angles.
Prestige Consumer (PBH) Tops Q2 Earnings & Revenue Estimates
by Zacks Equity Research
Prestige Consumer's (PBH) Q2 results reflect gains from solid demand and continued recovery in certain categories. Encouragingly, it raises the fiscal 2022 guidance.
Prestige Brands (PBH) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Prestige Brands (PBH) delivered earnings and revenue surprises of 3.03% and 5.71%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Prestige Consumer (PBH) to Post Q2 Earnings: Things to Note
by Zacks Equity Research
Prestige Consumer's (PBH) performance in the fiscal second quarter is likely to have gained from strong brand offerings, especially in healthcare, as well as growing e-commerce sales.
Prestige Brands (PBH) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LCUT vs. PBH: Which Stock Is the Better Value Option?
by Zacks Equity Research
LCUT vs. PBH: Which Stock Is the Better Value Option?
Prestige Consumer Healthcare (PBH) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Prestige Consumer Healthcare (PBH) has been struggling lately, but the selling pressure may be coming to an end soon.
Central Garden & Pet (CENT) Solid on Buyouts & Digital Efforts
by Zacks Equity Research
Central Garden & Pet (CENT) banks on its robust business strategies. It is steadily advancing its digital capabilities and making wise acquisitions to boost growth.
LCUT vs. PBH: Which Stock Is the Better Value Option?
by Zacks Equity Research
LCUT vs. PBH: Which Stock Is the Better Value Option?
Spectrum Brands (SPB) to Divest HHI to Focus on Core Units
by Zacks Equity Research
Spectrum Brands (SPB) agrees to sell off its HHI segment to effectively focus on its three core profitable units and strengthen its balance sheet.
Prestige Consumer (PBH) Surges More Than 65% YTD: Here's Why
by Zacks Equity Research
Prestige Consumer (PBH) is consistently making multi-year e-commerce investments, which are yielding well. The company is focusing on the areas with significant prospects, such as healthcare.
The Zacks Analyst Blog Highlights: Lifetime Brands, Alto Ingredients, Party City Holdco, Prestige Consumer Healthcare and RCI Hospitality
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Lifetime Brands, Alto Ingredients, Party City Holdco, Prestige Consumer Healthcare and RCI Hospitality
Earnings Estimates Rising for Prestige Brands (PBH): Will It Gain?
by Zacks Equity Research
Prestige Brands (PBH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.